Disease block
N17-N19 – Niereninsuffizienz
- Chapter XIV: Krankheiten des Urogenitalsystems
9Decisions
11Patient groups
Added benefit by patient group
- Considerable1
- Minor1
- Non-quantifiable2
- Not proven7
Diseases in this disease block
- N18 Chronische Nierenkrankheit 9 decisions
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2024-11-22VafseoVadadustatNot proven
- 2024-02-01JardianceEmpagliflozinNot proven
- 2023-08-17KerendiaFinerenonNon-quantifiable
- 2023-08-17KerendiaFinerenonNot proven
- 2022-03-03EvrenzoRoxadustatNot proven
- 2022-02-17ForxigaDapagliflozinConsiderable: 1 of 2 patient groupsMinor: 1 of 2 patient groups
- 2021-09-02IdefirixImlifidaseNon-quantifiable
- 2021-06-03VelphoroSucroferric OxyhydroxideNot proven
- 2015-03-19VelphoroSucroferric OxyhydroxideNot proven: 2 of 2 patient groups
Data status: 2026-10-29